Article
2m Read
April 28, 2025
RESPIRATORY HEALTH
The Need
- SARS-CoV-2 infections are associated with increased morbidity, mortality, cost and pose an ever-present threat to public health globally.1,2
- SARS-CoV-2 variants continue to emerge, resulting in the risk of new surge cases and death.2
- Testing required to identify the breakthrough infections and informing patient care, especially for the high-risk population.3
1 WHO Coronavirus (COVID-19) Dashboard – Last accessed 22nd Sep 2023
2 https://news.un.org/en/story/2023/05/1136367
3 Peeling RW, Heymann DL, Teo YY, Garcia PJ. Diagnostics for COVID-19: moving from pandemic response to control. Lancet. 2022 Feb 19;399(10326):757-768. doi: 10.1016/
S0140-6736(21)02346-1. Epub 2021 Dec 20. PMID: 34942102; PMCID: PMC8687671
2 https://news.un.org/en/story/2023/05/1136367
3 Peeling RW, Heymann DL, Teo YY, Garcia PJ. Diagnostics for COVID-19: moving from pandemic response to control. Lancet. 2022 Feb 19;399(10326):757-768. doi: 10.1016/
S0140-6736(21)02346-1. Epub 2021 Dec 20. PMID: 34942102; PMCID: PMC8687671
The Solution
- The Xpert Xpress CoV-2 plus test is a fast, real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal and anterior nasal swab specimens collected from individuals with signs and symptoms of respiratory tract infection by their healthcare provider.
- The test provides actionable results in as early as 19 minutes.* It was designed with three gene targets for the detection of SARS-CoV-2, providing target redundancy to mitigate potential impact of genetic mutations.
* With early assay termination for positives, otherwise, the full test runtime is 30 minutes
The Impact
- Support clinicians with broader coverage for SARS-CoV-2 variants with a three-gene target design.
- Rapid PCR workflows can reduce time to result, isolation times, and total costs while optimizing capacity. 5
- Enable patients to receive timely and appropriate treatment.4
4 Shah MM, Joyce B, Plumb ID, et al. Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022. MMWR Morb Mortal Wkly Rep 2022;71:1531–1537.
5 Fistera D, Kikull K, Risse J, Herrmann A, Brachmann M, Kill C. Point-of-care PCR testing of SARS-CoV-2 in the emergency department: Influence on workflow and efficiency. PLoS One. 2023 Aug 3;18(8) https://pubmed.ncbi.nlm.nih.gov/37535577
5 Fistera D, Kikull K, Risse J, Herrmann A, Brachmann M, Kill C. Point-of-care PCR testing of SARS-CoV-2 in the emergency department: Influence on workflow and efficiency. PLoS One. 2023 Aug 3;18(8) https://pubmed.ncbi.nlm.nih.gov/37535577